LU505383B1 - Microfluidic chip for screening migration of mesenchymal stem cell (msc) to tumor, and preparation method and use method thereof - Google Patents
Microfluidic chip for screening migration of mesenchymal stem cell (msc) to tumor, and preparation method and use method thereof Download PDFInfo
- Publication number
- LU505383B1 LU505383B1 LU505383A LU505383A LU505383B1 LU 505383 B1 LU505383 B1 LU 505383B1 LU 505383 A LU505383 A LU 505383A LU 505383 A LU505383 A LU 505383A LU 505383 B1 LU505383 B1 LU 505383B1
- Authority
- LU
- Luxembourg
- Prior art keywords
- cell
- channel
- microfluidic chip
- migration
- matrigel
- Prior art date
Links
- 230000005012 migration Effects 0.000 title claims abstract description 49
- 238000013508 migration Methods 0.000 title claims abstract description 49
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 41
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 39
- 238000012216 screening Methods 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000004113 cell culture Methods 0.000 claims abstract description 111
- 108010082117 matrigel Proteins 0.000 claims abstract description 63
- 230000010412 perfusion Effects 0.000 claims abstract description 50
- 230000012292 cell migration Effects 0.000 claims abstract description 46
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 210000004027 cell Anatomy 0.000 claims description 100
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 58
- 210000004881 tumor cell Anatomy 0.000 claims description 37
- 239000006285 cell suspension Substances 0.000 claims description 21
- 239000011159 matrix material Substances 0.000 claims description 21
- 239000000700 radioactive tracer Substances 0.000 claims description 16
- 210000000056 organ Anatomy 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000012544 monitoring process Methods 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 5
- 108010022355 Fibroins Proteins 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000007850 fluorescent dye Substances 0.000 claims description 5
- 238000001215 fluorescent labelling Methods 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 5
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000003399 chemotactic effect Effects 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 230000003993 interaction Effects 0.000 claims description 3
- 238000005459 micromachining Methods 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000008054 signal transmission Effects 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000008223 sterile water Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- -1 polydimethylsiloxane Polymers 0.000 claims description 2
- 239000002609 medium Substances 0.000 description 25
- 210000001519 tissue Anatomy 0.000 description 19
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 17
- 101000827688 Homo sapiens Fibroblast growth factor receptor 2 Proteins 0.000 description 17
- 230000035605 chemotaxis Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- IPJDHSYCSQAODE-UHFFFAOYSA-N 5-chloromethylfluorescein diacetate Chemical compound O1C(=O)C2=CC(CCl)=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 IPJDHSYCSQAODE-UHFFFAOYSA-N 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- 206010008342 Cervix carcinoma Diseases 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 201000010881 cervical cancer Diseases 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 102000046949 human MSC Human genes 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002174 soft lithography Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
- C12N2535/10—Patterned coating
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Dispersion Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Clinical Laboratory Science (AREA)
- Oncology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211270154.3A CN117264763A (zh) | 2022-10-18 | 2022-10-18 | 一种用于间充质干细胞迁移筛选的肿瘤微流控芯片及其制备和应用方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU505383B1 true LU505383B1 (en) | 2024-04-26 |
Family
ID=89203252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU505383A LU505383B1 (en) | 2022-10-18 | 2022-12-22 | Microfluidic chip for screening migration of mesenchymal stem cell (msc) to tumor, and preparation method and use method thereof |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN117264763A (zh) |
| LU (1) | LU505383B1 (zh) |
| WO (1) | WO2024082430A1 (zh) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2274438A4 (en) * | 2008-04-08 | 2013-09-11 | Massachusetts Inst Technology | THREE-DIMENSIONAL MICROFLUIDIC PLATFORMS AND METHODS OF USING THE SAME |
| CN103627635B (zh) * | 2013-11-18 | 2015-05-20 | 辽宁中医药大学 | 一种用于细胞迁移和侵袭实验的多功能微流控芯片 |
| CN105713835B (zh) * | 2014-12-05 | 2018-11-09 | 中国科学院大连化学物理研究所 | 一种基于微流控芯片的多功能区域细胞三维共培养方法 |
| CN106566863B (zh) * | 2015-10-10 | 2020-11-20 | 中国科学院大连化学物理研究所 | 一种基于微流控芯片的细胞双向侵袭监测方法 |
| CN107955783B (zh) * | 2016-10-14 | 2021-11-30 | 中国科学院大连化学物理研究所 | 一种基于微流控芯片体外糖尿病肾小球模型的构建方法 |
| CN107955784B (zh) * | 2016-10-14 | 2021-10-15 | 中国科学院大连化学物理研究所 | 一种基于微流控芯片技术的三维细胞球迁移监测方法 |
| CN106544271A (zh) * | 2016-12-07 | 2017-03-29 | 清华大学深圳研究生院 | 一种研究肿瘤侵袭血管的多细胞3d共培养装置和方法 |
| CN114480122A (zh) * | 2022-01-24 | 2022-05-13 | 中国人民解放军海军军医大学 | 一种基于微流控芯片的血脑屏障与脑胶质瘤共培养模型的建立方法及应用 |
-
2022
- 2022-10-18 CN CN202211270154.3A patent/CN117264763A/zh active Pending
- 2022-12-22 WO PCT/CN2022/140871 patent/WO2024082430A1/zh unknown
- 2022-12-22 LU LU505383A patent/LU505383B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN117264763A (zh) | 2023-12-22 |
| WO2024082430A1 (zh) | 2024-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109432127A (zh) | 间充质干细胞外泌体在制备促毛发再生的药物制剂中的应用 | |
| CN103898058B (zh) | 一种新型胶质瘤干细胞的三维培养方法及其应用 | |
| CN102465113B (zh) | 一种人肝癌细胞系及其应用 | |
| CN106754668A (zh) | 一种干细胞培养液及注射液 | |
| CN102021116A (zh) | 一种微流控芯片及其研究非接触式细胞共培养的方法 | |
| CN102382758A (zh) | 基于细胞打印和多参数传感阵列集成技术的三维细胞芯片 | |
| CN102787071A (zh) | 基于微流控芯片系统的模拟体内流体剪切力细胞行为研究 | |
| Dvořánková et al. | Isolation of normal fibroblasts and their cancer-associated counterparts (CAFs) for biomedical research | |
| CN104164360B (zh) | 集成微流控芯片及其用于三维肿瘤定位、构建、回收方法 | |
| CN108795851A (zh) | 一种人唾液腺腺样囊性癌癌相关成纤维细胞系caf-sa的建立方法及其应用 | |
| CN109182257A (zh) | 一种提高软骨细胞增殖活性、维持软骨表型的力学环境培养方法 | |
| CN112481212A (zh) | 一种利用多能干细胞生成脑部类器官的方法 | |
| CN106566863A (zh) | 一种基于微流控芯片的细胞双向侵袭监测方法 | |
| CN113846016B (zh) | 一种高通量多孔阵列芯片、装置、制备方法及应用 | |
| LU505383B1 (en) | Microfluidic chip for screening migration of mesenchymal stem cell (msc) to tumor, and preparation method and use method thereof | |
| CN106244530A (zh) | 一种细胞培养液及其应用和诱导骨骼肌干细胞向心肌样细胞分化的方法 | |
| Saini et al. | Fabrication Method of a High-Density Co-Culture Tumor–Stroma Platform to Study Cancer Progression | |
| CN114214282B (zh) | 一种培养肺肿瘤类器官的方法 | |
| CN108982846A (zh) | 脑胶质瘤相关间充质干细胞亚群生物特性的检测方法 | |
| Aydoğdu et al. | Isolation, culture, cryopreservation, and preparation of skin-derived fibroblasts as a final cellular product under good manufacturing practice–compliant conditions | |
| CN114989977A (zh) | 一种用于多细胞相互作用及药物筛选的肿瘤类器官芯片及其制备方法 | |
| CN104357542A (zh) | 红色毛癣菌角蛋白酶活性的测定方法 | |
| CN103396946A (zh) | 生物反应装置及其制备方法和应用 | |
| CN113817683A (zh) | 一种肺癌类器官的培养基及其应用 | |
| RU2517112C2 (ru) | Способ культивирования мезенхимных стволовых клеток, выделенных из костного мозга |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Effective date: 20240426 |